Production (Stage)
Autolus Therapeutics plc
AUTL
$1.54
$0.010.65%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -70.16M | -27.61M | -82.09M | -58.27M | -52.69M |
| Total Depreciation and Amortization | 2.28M | 2.08M | 1.94M | 1.90M | 1.81M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.02M | -9.42M | 1.42M | 14.21M | 24.12M |
| Change in Net Operating Assets | -17.70M | -2.99M | 2.00M | -8.92M | -13.75M |
| Cash from Operations | -75.57M | -37.93M | -76.74M | -51.08M | -40.51M |
| Capital Expenditure | -8.24M | -11.11M | -9.59M | -841.00K | -533.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -51.30M | -372.48M | -- | -- | -- |
| Cash from Investing | -59.55M | -383.59M | -9.59M | -841.00K | -533.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 7.00K | 185.00K | 125.00K | 550.26M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 30.00M | 0.00 | -2.20M | 11.18M |
| Cash from Financing | -- | 30.01M | 185.00K | -2.08M | 561.44M |
| Foreign Exchange rate Adjustments | 3.56M | -38.22M | 37.72M | 1.42M | -1.19M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -131.55M | -429.73M | -48.42M | -52.59M | 519.21M |